<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00860470</url>
  </required_header>
  <id_info>
    <org_study_id>JHU_IRB 570</org_study_id>
    <nct_id>NCT00860470</nct_id>
  </id_info>
  <brief_title>Antenatal Micronutrient Supplementation and Infant Survival</brief_title>
  <acronym>JiVitA-3</acronym>
  <official_title>Antenatal Multiple Micronutrient Supplementation to Improve Infant Survival and Health in Bangladesh</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins Bloomberg School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bill and Melinda Gates Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>United States Agency for International Development (USAID)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beximco</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>DSM Nutritional Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins Bloomberg School of Public Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this community-based randomized trial is to examine whether a daily antenatal
      and postnatal multiple micronutrient supplement given to women will enhance newborn and
      infant survival and health and other birth outcomes in a rural setting in northwestern
      Bangladesh.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Maternal deficiency in multiple essential micronutrients is likely to be a major public
      health problem in low-income countries. Supplementing mothers with certain individual
      micronutrients has been shown to confer health benefits, although the evidence is not clear
      for multiple micronutrients. We aim to test, in a cluster-randomized, double-masked,
      controlled trial whether giving a daily multiple micronutrient supplement (similar in
      composition to the UNICEF antenatal supplement) will enhance infant survival and birth
      outcomes such as birth weight and gestational duration in a rural population in Bangladesh.
      Over the duration of 2-3 years a community-surveillance in the northwestern, rural Districts
      of Gaibandha and Southern Rangpur, the trial plans to identify and recruit 45,000 pregnant
      women based on 5-weekly histories of amenorrhea confirmed by urine-testing, and supplement
      them with either a multiple micronutrient supplement or an iron-folic acid supplement (as the
      standard of care control for pregnancy) and monitor pregnancy health, birth outcomes and
      vital status and health of liveborn infants through 6 months of age. In a ~3% sub-sample of
      mothers, additional measures of nutritional and health status will be evaluated in the 1st
      and 3rd trimesters of pregnancy, and at 3 months postpartum (with infants), that include
      anthropometric and body composition (bioelectrical impedance) assessment, collection of
      biospecimens (eg, phlebotomy and breast milk sampling for micronutrient and other analyte
      concentration determinations), and other clinical assessments. The trial will generate
      evidence from which to examine the safety and efficacy of an antenatal through postnatal
      maternal micronutrient supplement intervention in order to inform and guide antenatal
      nutrition policies and programs in South Asia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infant Mortality Through 6 mo of Age</measure>
    <time_frame>Dec 2014</time_frame>
    <description>Risk of Infant Mortality to Age 6 months (180 days)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neonatal Mortality</measure>
    <time_frame>Dec 2014</time_frame>
    <description>Risk of neonatal Mortality (28 days of life)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-neonatal Mortality</measure>
    <time_frame>Dec 2014</time_frame>
    <description>Risk of Post-neonatal Mortality (29th -180th day of life)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Still Birth Rates</measure>
    <time_frame>December 2014</time_frame>
    <description>Risk of Still birth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preterm Birth</measure>
    <time_frame>December 2014</time_frame>
    <description>Risk of being born before 37 weeks of gestation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extremely Pre-term</measure>
    <time_frame>December 2014</time_frame>
    <description>Risk of birth before 28 weeks gestation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Very Pre-term</measure>
    <time_frame>December 2014</time_frame>
    <description>Risk of birth between 28 and 32 weeks of gestation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Moderate to Late Preterm</measure>
    <time_frame>December 2014</time_frame>
    <description>Risk of birth between 32 and 37 weeks gestation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low Birth Weight</measure>
    <time_frame>December 2014</time_frame>
    <description>Birth weight below 2500g</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Small for Gestation Age</measure>
    <time_frame>December 2014</time_frame>
    <description>Small for Gestational Age defined as birth weight &lt;10th percentile of a standard reference (Alexander GR, Himes JH, Kaufman RB, et al. Obstet Gynecol. 1996;87(2):163-68).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44567</enrollment>
  <condition>Infant Mortality</condition>
  <condition>Preterm Birth</condition>
  <condition>Low Birth Weight</condition>
  <condition>Neonatal Mortality</condition>
  <condition>Perinatal Mortality</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Iron (27 mg) and folic acid (600 ug)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multiple micronutrient</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Iron (27 mg) - folic acid (600 ug)</intervention_name>
    <description>Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>iron-folate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multiple micronutrient</intervention_name>
    <description>Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>one-a-day multivitamin</other_name>
    <other_name>antenatal micronutrient</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant and consents to participate

        Exclusion Criteria:

          -  Not interviewed for consent within 12 consecutive weeks after being ascertained as
             pregnant by urine testing
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keith P West, Jr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins Bloomberg School of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Parul Christian</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins Bloomberg School of Public Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins School of Public Health</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JiVitA Project Office</name>
      <address>
        <city>Rangpur</city>
        <state>Gaibandha District</state>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.jhsph.edu/chn/research/jivita1.html</url>
    <description>Basic description of the JiVitA project, location and individuals</description>
  </link>
  <reference>
    <citation>Christian P, Khatry SK, Katz J, Pradhan EK, LeClerq SC, Shrestha SR, Adhikari RK, Sommer A, West KP Jr. Effects of alternative maternal micronutrient supplements on low birth weight in rural Nepal: double blind randomised community trial. BMJ. 2003 Mar 15;326(7389):571.</citation>
    <PMID>12637400</PMID>
  </reference>
  <reference>
    <citation>Christian P. Micronutrients and reproductive health issues: an international perspective. J Nutr. 2003 Jun;133(6):1969S-1973S. Review.</citation>
    <PMID>12771347</PMID>
  </reference>
  <reference>
    <citation>Christian P, Shrestha J, LeClerq SC, Khatry SK, Jiang T, Wagner T, Katz J, West KP Jr. Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal. J Nutr. 2003 Nov;133(11):3492-8.</citation>
    <PMID>14608063</PMID>
  </reference>
  <reference>
    <citation>Christian P, West KP, Khatry SK, Leclerq SC, Pradhan EK, Katz J, Shrestha SR, Sommer A. Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal. Am J Clin Nutr. 2003 Dec;78(6):1194-202.</citation>
    <PMID>14668283</PMID>
  </reference>
  <reference>
    <citation>Katz J, West KP Jr, Khatry SK, Christian P, LeClerq SC, Pradhan EK, Shrestha SR. Risk factors for early infant mortality in Sarlahi district, Nepal. Bull World Health Organ. 2003;81(10):717-25. Epub 2003 Nov 25.</citation>
    <PMID>14758431</PMID>
  </reference>
  <reference>
    <citation>Jiang T, Christian P, Khatry SK, Wu L, West KP Jr. Micronutrient deficiencies in early pregnancy are common, concurrent, and vary by season among rural Nepali pregnant women. J Nutr. 2005 May;135(5):1106-12.</citation>
    <PMID>15867289</PMID>
  </reference>
  <reference>
    <citation>Christian P, Osrin D, Manandhar DS, Khatry SK, de L Costello AM, West KP Jr. Antenatal micronutrient supplements in Nepal. Lancet. 2005 Aug 27-Sep 2;366(9487):711-2.</citation>
    <PMID>16125578</PMID>
  </reference>
  <reference>
    <citation>Christian P, Jiang T, Khatry SK, LeClerq SC, Shrestha SR, West KP Jr. Antenatal supplementation with micronutrients and biochemical indicators of status and subclinical infection in rural Nepal. Am J Clin Nutr. 2006 Apr;83(4):788-94.</citation>
    <PMID>16600929</PMID>
  </reference>
  <reference>
    <citation>Katz J, Christian P, Dominici F, Zeger SL. Treatment effects of maternal micronutrient supplementation vary by percentiles of the birth weight distribution in rural Nepal. J Nutr. 2006 May;136(5):1389-94.</citation>
    <PMID>16614435</PMID>
  </reference>
  <reference>
    <citation>West KP Jr, Christian P. Antenatal micronutrients in undernourished people. Lancet. 2008 Feb 9;371(9611):452-4. doi: 10.1016/S0140-6736(08)60214-7.</citation>
    <PMID>18262025</PMID>
  </reference>
  <reference>
    <citation>Christian P, Darmstadt GL, Wu L, Khatry SK, Leclerq SC, Katz J, West KP Jr, Adhikari RK. The effect of maternal micronutrient supplementation on early neonatal morbidity in rural Nepal: a randomised, controlled, community trial. Arch Dis Child. 2008 Aug;93(8):660-4. doi: 10.1136/adc.2006.114009.</citation>
    <PMID>18644934</PMID>
  </reference>
  <reference>
    <citation>Shankar AH, Genton B, Baisor M, Paino J, Tamja S, Adiguma T, Wu L, Rare L, Bannon D, Tielsch JM, West KP Jr, Alpers MP. The influence of zinc supplementation on morbidity due to Plasmodium falciparum: a randomized trial in preschool children in Papua New Guinea. Am J Trop Med Hyg. 2000 Jun;62(6):663-9.</citation>
    <PMID>11304051</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2009</study_first_submitted>
  <study_first_submitted_qc>March 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2009</study_first_posted>
  <results_first_submitted>May 7, 2015</results_first_submitted>
  <results_first_submitted_qc>May 7, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 27, 2015</results_first_posted>
  <last_update_submitted>May 7, 2015</last_update_submitted>
  <last_update_submitted_qc>May 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins Bloomberg School of Public Health</investigator_affiliation>
    <investigator_full_name>Keith P. West</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>micronutrients</keyword>
  <keyword>deficiency</keyword>
  <keyword>pregnancy</keyword>
  <keyword>birth outcomes</keyword>
  <keyword>infant mortality</keyword>
  <keyword>neonatal mortality</keyword>
  <keyword>malnutrition</keyword>
  <keyword>antenatal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Birth Weight</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Infant Death</mesh_term>
    <mesh_term>Perinatal Death</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
    <mesh_term>Trace Elements</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Micronutrients</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Enumeration of women began in December 2007, and active recruitment of pregnant women into the trail began in January 2008. Women were enrolled into the trial by community workers from the projects who visited them at home.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Iron and Folate</title>
          <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
        </group>
        <group group_id="P2">
          <title>Multiple Micronutrient</title>
          <description>Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22162"/>
                <participants group_id="P2" count="22405"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22114"/>
                <participants group_id="P2" count="22346"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Moved away</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Iron and Folate</title>
          <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
        </group>
        <group group_id="B2">
          <title>Multiple Micronutrient</title>
          <description>Multiple micronutrient
Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22162"/>
            <count group_id="B2" value="22405"/>
            <count group_id="B3" value="44567"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.3" spread="6.43"/>
                    <measurement group_id="B2" value="24.4" spread="6.44"/>
                    <measurement group_id="B3" value="24.3" spread="6.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22,162"/>
                    <measurement group_id="B2" value="22,405"/>
                    <measurement group_id="B3" value="44567"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Asian, Bangladeshi</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22,162"/>
                    <measurement group_id="B2" value="22,405"/>
                    <measurement group_id="B3" value="44567"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Bangladesh</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22,162"/>
                    <measurement group_id="B2" value="22,405"/>
                    <measurement group_id="B3" value="44567"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational Age in weeks</title>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.34" spread="4.7"/>
                    <measurement group_id="B2" value="10.28" spread="4.7"/>
                    <measurement group_id="B3" value="10.30" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Literacy</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Literate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12,816"/>
                    <measurement group_id="B2" value="12,985"/>
                    <measurement group_id="B3" value="25801"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Illiterate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9,346"/>
                    <measurement group_id="B2" value="9,420"/>
                    <measurement group_id="B3" value="18766"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Parity</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6,671"/>
                    <measurement group_id="B2" value="6,647"/>
                    <measurement group_id="B3" value="13318"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1-3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13,255"/>
                    <measurement group_id="B2" value="13,520"/>
                    <measurement group_id="B3" value="26775"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2,186"/>
                    <measurement group_id="B2" value="2,194"/>
                    <measurement group_id="B3" value="4380"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Pregnancy Loss</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4,974"/>
                    <measurement group_id="B2" value="5,106"/>
                    <measurement group_id="B3" value="10080"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Infant Mortality Through 6 mo of Age</title>
        <description>Risk of Infant Mortality to Age 6 months (180 days)</description>
        <time_frame>Dec 2014</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Iron and Folate</title>
            <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
          <group group_id="O2">
            <title>Multiple Micronutrient</title>
            <description>Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
        </group_list>
        <measure>
          <title>Infant Mortality Through 6 mo of Age</title>
          <description>Risk of Infant Mortality to Age 6 months (180 days)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14142"/>
                <count group_id="O2" value="14374"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="764"/>
                    <measurement group_id="O2" value="741"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.36</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Bonferroni-adjusted alpha=0.01 (for 5 comparisons)</method_desc>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.95</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.86</ci_lower_limit>
            <ci_upper_limit>1.06</ci_upper_limit>
            <estimate_desc>GEE with log link function and exchangeable correlation was used to adjust confidence intervals for cluster randomised design; the iron-folic acid supplemented group was the referent.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neonatal Mortality</title>
        <description>Risk of neonatal Mortality (28 days of life)</description>
        <time_frame>Dec 2014</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Iron and Folate</title>
            <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
          <group group_id="O2">
            <title>Multiple Micronutrient</title>
            <description>Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Mortality</title>
          <description>Risk of neonatal Mortality (28 days of life)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14142"/>
                <count group_id="O2" value="14374"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="625"/>
                    <measurement group_id="O2" value="626"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.78</p_value>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.98</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.88</ci_lower_limit>
            <ci_upper_limit>1.20</ci_upper_limit>
            <estimate_desc>GEE with log link function and exchangeable correlation was used to adjust confidence intervals for cluster randomised design; the iron-folic acid supplemented group was the referent.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-neonatal Mortality</title>
        <description>Risk of Post-neonatal Mortality (29th -180th day of life)</description>
        <time_frame>Dec 2014</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Iron and Folate</title>
            <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
          <group group_id="O2">
            <title>Multiple Micronutrient</title>
            <description>Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
        </group_list>
        <measure>
          <title>Post-neonatal Mortality</title>
          <description>Risk of Post-neonatal Mortality (29th -180th day of life)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13517"/>
                <count group_id="O2" value="13748"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139"/>
                    <measurement group_id="O2" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.11</p_value>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.81</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.63</ci_lower_limit>
            <ci_upper_limit>1.04</ci_upper_limit>
            <estimate_desc>GEE with log link function and exchangeable correlation was used to adjust confidence intervals for cluster randomised design; the iron-folic acid supplemented group was the referent.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Still Birth Rates</title>
        <description>Risk of Still birth</description>
        <time_frame>December 2014</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Iron and Folate</title>
            <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
          <group group_id="O2">
            <title>Multiple Micronutrient</title>
            <description>Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
        </group_list>
        <measure>
          <title>Still Birth Rates</title>
          <description>Risk of Still birth</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14858"/>
                <count group_id="O2" value="15022"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="716"/>
                    <measurement group_id="O2" value="648"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Bonferroni-adjusted alpha=0.01 (for 5 comparisons)</method_desc>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.89</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
            <estimate_desc>GEE with log link function and exchangeable correlation was used to adjust confidence intervals for cluster randomised design; the iron-folic acid supplemented group was the referent.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Preterm Birth</title>
        <description>Risk of being born before 37 weeks of gestation</description>
        <time_frame>December 2014</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Iron and Folate</title>
            <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
          <group group_id="O2">
            <title>Multiple Micronutrient</title>
            <description>Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
        </group_list>
        <measure>
          <title>Preterm Birth</title>
          <description>Risk of being born before 37 weeks of gestation</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13333"/>
                <count group_id="O2" value="13475"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2912"/>
                    <measurement group_id="O2" value="2510"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Bonferroni-adjusted alpha=0.01 (for 5 comparisons)</method_desc>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.85</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.80</ci_lower_limit>
            <ci_upper_limit>0.91</ci_upper_limit>
            <estimate_desc>GEE with log link function and exchangeable correlation was used to adjust confidence intervals for cluster randomised design; the iron-folic acid supplemented group was the referent.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Extremely Pre-term</title>
        <description>Risk of birth before 28 weeks gestation</description>
        <time_frame>December 2014</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Iron and Folate</title>
            <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
          <group group_id="O2">
            <title>Multiple Micronutrient</title>
            <description>Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
        </group_list>
        <measure>
          <title>Extremely Pre-term</title>
          <description>Risk of birth before 28 weeks gestation</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13333"/>
                <count group_id="O2" value="13475"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="136"/>
                    <measurement group_id="O2" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.75</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>0.97</ci_upper_limit>
            <estimate_desc>GEE with log link function and exchangeable correlation was used to adjust confidence intervals for cluster randomised design; the iron-folic acid supplemented group was the referent.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Very Pre-term</title>
        <description>Risk of birth between 28 and 32 weeks of gestation</description>
        <time_frame>December 2014</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Iron and Folate</title>
            <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
          <group group_id="O2">
            <title>Multiple Micronutrient</title>
            <description>Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
        </group_list>
        <measure>
          <title>Very Pre-term</title>
          <description>Risk of birth between 28 and 32 weeks of gestation</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13333"/>
                <count group_id="O2" value="13475"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="385"/>
                    <measurement group_id="O2" value="291"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.73</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.62</ci_lower_limit>
            <ci_upper_limit>0.86</ci_upper_limit>
            <estimate_desc>GEE with log link function and exchangeable correlation was used to adjust confidence intervals for cluster randomised design; the iron-folic acid supplemented group was the referent.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Moderate to Late Preterm</title>
        <description>Risk of birth between 32 and 37 weeks gestation</description>
        <time_frame>December 2014</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Iron and Folate</title>
            <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
          <group group_id="O2">
            <title>Multiple Micronutrient</title>
            <description>Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
        </group_list>
        <measure>
          <title>Moderate to Late Preterm</title>
          <description>Risk of birth between 32 and 37 weeks gestation</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1333"/>
                <count group_id="O2" value="13475"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2391"/>
                    <measurement group_id="O2" value="2113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.87</p_value>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.87</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>0.93</ci_upper_limit>
            <estimate_desc>GEE with log link function and exchangeable correlation was used to adjust confidence intervals for cluster randomised design; the iron-folic acid supplemented group was the referent.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Low Birth Weight</title>
        <description>Birth weight below 2500g</description>
        <time_frame>December 2014</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Iron and Folate</title>
            <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
          <group group_id="O2">
            <title>Multiple Micronutrient</title>
            <description>Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
        </group_list>
        <measure>
          <title>Low Birth Weight</title>
          <description>Birth weight below 2500g</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10530"/>
                <count group_id="O2" value="10642"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4809"/>
                    <measurement group_id="O2" value="4275"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Bonferroni-adjusted alpha=0.01 (for 5 comparisons)</method_desc>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.88</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.85</ci_lower_limit>
            <ci_upper_limit>0.91</ci_upper_limit>
            <estimate_desc>GEE with log link function and exchangeable correlation was used to adjust confidence intervals for cluster randomised design; the iron-folic acid supplemented group was the referent.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Small for Gestation Age</title>
        <description>Small for Gestational Age defined as birth weight &lt;10th percentile of a standard reference (Alexander GR, Himes JH, Kaufman RB, et al. Obstet Gynecol. 1996;87(2):163-68).</description>
        <time_frame>December 2014</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Iron and Folate</title>
            <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
          <group group_id="O2">
            <title>Multiple Micronutrient</title>
            <description>Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
          </group>
        </group_list>
        <measure>
          <title>Small for Gestation Age</title>
          <description>Small for Gestational Age defined as birth weight &lt;10th percentile of a standard reference (Alexander GR, Himes JH, Kaufman RB, et al. Obstet Gynecol. 1996;87(2):163-68).</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10099"/>
                <count group_id="O2" value="10161"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6479"/>
                    <measurement group_id="O2" value="6405"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.13</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Bonferroni-adjusted alpha=0.01 (for 5 comparisons)</method_desc>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.98</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.96</ci_lower_limit>
            <ci_upper_limit>1.01</ci_upper_limit>
            <estimate_desc>GEE with log link function and exchangeable correlation was used to adjust confidence intervals for cluster randomised design; the iron-folic acid supplemented group was the referent.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Iron (27 mg) and Folic Acid (600 ug)</title>
          <description>Iron (27 mg) and folic acid (600 ug)
Iron (27 mg) - folic acid (600 ug): Supplement serves as the &quot;Control&quot; (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
        </group>
        <group group_id="E2">
          <title>Multiple Micronutrient</title>
          <description>Multiple micronutrient
Multiple micronutrient: Containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug).
Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks post-partum.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22114"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22346"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22114"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22346"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study was run in an area where iron deficiency rates were low.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Keith P. West, Jr.</name_or_title>
      <organization>JHSPH</organization>
      <phone>4109552061</phone>
      <email>kwest@jhsph.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

